Elevance Health (ELV) Common Equity (2009 - 2026)

Elevance Health (ELV) has 18 years of Common Equity data on file, last reported at $45.0 billion in Q2 2026.

• On a quarterly basis, Common Equity rose 2.67% year-over-year to $45.0 billion in Q2 2026; TTM through Jun 2026 was $45.0 billion, a 2.67% increase from a year earlier, with the FY2025 full-year figure at $43.9 billion, up 5.93% from the prior year.
• Common Equity for Q2 2026 stood at $45.0 billion, up from $44.0 billion in the prior quarter.
• Over the last five years, Common Equity for ELV reached as high as $45.0 billion in Q2 2026 and fell as low as $35.9 billion in Q2 2022.
• Historically, Common Equity has averaged $40.5 billion across 5 years, with a median of $41.1 billion in 2024.
• Across the five-year window, Common Equity grew 13.86% in 2024 and climbed 0.17% in 2025, its largest moves.
• Year by year, Common Equity stood at $36.3 billion in 2022, then rose by 8.46% to $39.4 billion in 2023, then increased by 5.13% to $41.4 billion in 2024, then advanced by 5.93% to $43.9 billion in 2025, then advanced by 2.6% to $45.0 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $45.0 billion in Q2 2026, $44.0 billion in Q1 2026, and $43.9 billion in Q4 2025.